Now Available: (Oroeze) Benzydamine 0.15% w/v Oromucosal Spray
2 pages
English

Now Available: (Oroeze) Benzydamine 0.15% w/v Oromucosal Spray

Le téléchargement nécessite un accès à la bibliothèque YouScribe
Tout savoir sur nos offres
2 pages
English
Le téléchargement nécessite un accès à la bibliothèque YouScribe
Tout savoir sur nos offres

Description

Now Available: (Oroeze) Benzydamine 0.15% w/v Oromucosal Spray PR Newswire CASTLEFORD, England, June 14, 2012 CASTLEFORD, England, June 14, 2012 /PRNewswire/ -- Teva UK Limited is pleased to launch (Oroeze) Benzydamine 0.15% w/v Oromucosal spray.

Informations

Publié par
Nombre de lectures 18
Langue English

Extrait

Now Available: (Oroeze) Benzydamine 0.15%
w/v Oromucosal Spray
PR Newswire
CASTLEFORD, England, June 14, 2012
CASTLEFORD, England
,
June 14, 2012
/PRNewswire/ --
Teva UK Limited is pleased to launch (Oroeze) Benzydamine 0.15% w/v
Oromucosal spray.
(Oroeze) Benzydamine Oromucosal spray is a version of brand leader's
Difflam
®
(Benzydamine) from Meda Pharmaceuticals. The Oroeze MA Holder is
Focus Pharmaceuticals.
It is indicated as a locally acting analgesic and anti-inflammatory treatment for
the throat and mouth. It is especially useful for the relief of pain in traumatic
conditions such as following tonsillectomy or the use of a naso-gastric tube;
dental surgery.
This product is available immediately in the award-winning Teva 360 livery, as
follows:
Product
(Oroeze) Benzydamine 0.15% w/v Oromucosal Spray x 1
Pack size
30ml x 1
Strength
0.15% w/v
Brand price
GBP3.63
Initial Teva retail price
GBP3.50
Kim Innes, Commercial Director at Teva, said: "As the leading supplier of
generic medicines and with the widest portfolio of our competitors, Teva
continues with strong product launches and patent expiries. We've already
launched eighteen new products this year including ten on day-one of patent
expiry."
New or existing customers can order through their local Teva Territory Sales
Manager, by completing the online form, or calling on
0800 085 8621
To find out more about Teva UK Limited, visit http://www.tevauk.com.
Notes to Editors:
About Teva UK Limited
Teva UK Limited is one of the UK's top ten pharmaceutical manufacturers, with
a presence in the generics, branded respiratory and hospitals markets. It has
the widest range of any UK generic pharmaceutical company and markets solid
and liquid dose, injectable and respiratory medicines to healthcare
professionals. The company is part of Teva Pharmaceutical Industries Ltd.
About Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global
pharmaceutical company, committed to increasing access to high-quality
healthcare by developing, producing and marketing affordable generic drugs as
well as innovative and specialty pharmaceuticals and active pharmaceutical
ingredients. Headquartered in
Israel
, Teva is the world's leading generic drug
maker, with a global product portfolio of more than 1,300 molecules and a
direct presence in about 60 countries. Teva's branded businesses focus on CNS,
oncology, pain, respiratory and women's health therapeutic areas as well as
biologics. Teva currently employs approximately 46,000 people around the
world and reached
$18.3 billion
in net revenues in 2011.
For media enquiries, contact the Teva UK Limited Media team on +44(0)1977-
628500, or email media.enquiries@tevauk.com.
  • Univers Univers
  • Ebooks Ebooks
  • Livres audio Livres audio
  • Presse Presse
  • Podcasts Podcasts
  • BD BD
  • Documents Documents